DVA News and Press, DaVita Inc. From 03/01/22

Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease - Company Acquires License to EA Pharma's Upacicalcet Worldwide Outside of Japan and Asia - - Industry Veteran Neal Fowler Named Chief Executive Officer of New Venture - ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips 2022 so far has been a challenging time to invest. Worries about pending interest rate hikes have put pressure on stocks. More recently, geopolitics has resulted in additional volatility . With this, and the end to th...

DaVita (NYSE:DVA) said a study suggested that dialysis patients who received Johnson & Johnson's (NYSE:JNJ) adenovirus vector-based COVID-19 vaccine were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis patients who received an mRNA-based va...

DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney Patients Research further demonstrates COVID-19 vaccination as an important clinical strategy to help protect vulnerable patients from infection PR Newswire DENVER , ...

The subsector with the best value and quality scores is pharmaceutical/biotechnology. Life science tools and healthcare equipment are the most overvalued. Fast facts on IDNA. A list of cheap stocks. For further details see: IDNA: Healthcare Dashboard For February

DaVita Kidney Care Appoints New Chief Medical Officer of Home Modalities Dr. Mihran Naljayan will take the clinical leadership role for DaVita PR Newswire DENVER , Feb. 16, 2022 /PRNewswire/ -- DaVita Kidney Care today announced Dr. Mihran Naljayan ...

Berkshire Hathaway's 13F stock portfolio value increased from ~$293B to ~$331B. Their largest three holdings are at over two-thirds of the entire portfolio. Berkshire Hathaway increased Chevron while reducing AbbVie, Marsh & McLennan, Bristol-Myers Squibb, Visa, and Royalty Ph...

DaVita expands paid leave to support teammates choosing to be living organ donors Company helps ease financial burden for living donors, encourages other employers to follow suit PR Newswire DENVER , Feb. 14, 2022 /PRNewswire/ -- In honor of National ...

DaVita provides essential dialysis services that are largely unavoidable for patients with end-stage kidney disease. The company operates in a duopolistic industry in which it has a 35% market share, strong bargaining powers and cost advantages. The company’s revenues are p...

Image source: The Motley Fool. DaVita (NYSE: DVA) Q4 2021 Earnings Call Feb 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: DaVita (DVA) Q4 2021 Earnings Call Transcript